Related Experiment Video
Updated: May 20, 2026
06:05
The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators
Liana Martirosyan1, Joekie Markhorst, Petra Denig
1Department of Clinical Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. ld.gross-martirosyan@cbg-meb.nl
BMC Health Services Research
|July 10, 2012
Summary
Stakeholders find prescribing quality indicators crucial for diabetes care assessment, with preferences varying by user aim. Addressing reasons for treatment deviations can enhance the use of these indicators for quality improvement.
Area of Science:
- Healthcare Quality Improvement
- Diabetes Care Management
- Health Services Research
Background:
- Prescribing quality information is essential for various stakeholders in diabetes care.
- Understanding stakeholder opinions on prescribing quality indicators is key for their effective implementation.
Purpose of the Study:
- To explore the opinions and preferences of key stakeholders regarding prescribing quality indicators for diabetes care.
- To identify barriers and facilitators for the use of prescribing quality indicators in healthcare quality improvement programs.
Main Methods:
- Semi-structured interviews were conducted with 16 key informants from eight Dutch healthcare organizations.
- Content analysis was applied to interview transcripts to identify themes related to stakeholder preferences and barriers.
Main Results:
- All stakeholders valued indicators for undertreatment; healthcare providers and policymakers favored safety indicators, insurers prioritized cost indicators, and patient representatives focused on interpersonal aspects.
- A composite score was preferred for initial assessment, but a lack of information on reasons for guideline deviations was a major barrier.
- Stakeholders preferred positive indicator formulations to encourage provider participation.
Conclusions:
- Prescribing quality indicators are valued for diabetes care assessment, but specific preferences differ among stakeholders.
- Implementing systems to record reasons for deviating from treatment guidelines could increase the use of these indicators.
- Study findings can inform the development of larger-scale surveys on quality indicators for diabetes care.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:19Quality Assurance
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:15Nursing Evaluation
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...
Section...